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Given the continued growth in the number of persons with cancer in the United States, the primary
prevention of cancer remains an urgent public health priority. As the ﬁeld of cancer prevention continues to
mature and scientiﬁc knowledge evolves, it is imperative to challenge the status quo and embrace new
approaches to cancer prevention. In this commentary, we summarize recent trends and some of the
scientiﬁc advances that have been made over the past few decades regarding the complex process of cancer
development and the interaction of individual and social risk factors. We examine some of the assumptions
and terminology that have characterized cancer prevention approaches for more than a quarter century and
the impact of these assumptions and our use of terminology. We propose that it is possible for today’s youth
to experience lower cancer incidence rates as adults compared with previous generations. To accomplish
this goal, a more transdisciplinary and multifaceted approach is needed, adapted as appropriate for different
populations and stages of life. The greatest improvements in cancer prevention may occur as a result of
innovative, multilevel interventions that build on the expanding scientiﬁc evidence base.
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Prevention has been the top cancer control objective for more
than a quarter century, but the promise of prevention remains
largely unfulﬁlled [1]. In cancer control, different approaches
exist for cancer prevention [2]. Efforts to detect cancer early or to
reduce second cancers among cancer survivors are termed
secondary prevention [3]. Primary prevention is the appropriate
term for efforts to reduce the incidence of disease. Primaryprevention is a traditional focus of public health, and it is the
topic of this article. Research during the past several decades has
vastly changed our understanding of cancer biology and the
complex interaction of risk factors at both the individual and
societal levels [4]. We argue that new approaches are needed to
address cancer prevention in public health that incorporate
different perspectives and challenge the status quo.Background
The National Cancer Act of 1971 is nowmore than 40 years old
[5]. During thepast fourdecades, our understandingof cancer risk
factors has advanced substantially as has our ability to detect and
treat cancer [6,7]. Despite these advances, each year about 1.5
million people in the United States are told they have cancer [8].
Although incidence rates formanycancershavedeclined since the
1970s,mostnotablyadecrease in lungcancer incidence in thepast
decade corresponding with reduced smoking prevalence [9],
incidence rates have increased during the past decade for all
childhood cancers and for some types of adult cancer, including
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certain types of esophageal and oropharyngeal cancers [10e14].
Figure 1 shows U.S. trends in total cancer incidence rates from
1973 to 2009 and illustrates how cancers with increasing inci-
dence rates have offset cancers with decreasing rates and
contributed to an overall increase in total cancer incidence during
this period. Some researchers attribute the increases in certain
cancers, in part, to the rising prevalence of obesity and increased
detection of early-stage tumors [12]. In general, however, the
reasons for the observed increases are not entirely known [13]. In
addition, because the U.S. population is aging, the total number of
incident cancer cases in the United States will continue to grow
unless we can reduce incidence rates considerably [15].Theories of Cancer Causation
Broadly speaking, cancer is the result ofmultiple alterations in
the processes that control cell proliferation, invasion, and spread.
Nearlyall cancers result frommultiple factors that inﬂuence these
processes over an extended time. In their recent update on the
hallmarks of cancer, Hanahan and Weinberg [16] describe the
multistep development of human tumors and the current
understanding of the complex biology of cancer. Although the
biology of cancer is still not completely understood, present
scientiﬁc ﬁndings point to multiple cellular pathways by which
different cancer risk factors could affect themultistep evolution of
normal cells into cancer cells during a person’s lifespan.
Many physical and chemical substances that cause cancer in
humans act through genetic changes that lead to downstream
changes in RNA and protein processing [17]. The most well-
studied and common genetic alterations in cancer include
mutations in oncogenes and tumor-suppressor genes. Normal
cells have multiple independent mechanisms that regulate cell
growth and differentiation. For cancer to begin and spread,
several separate events need to occur to override these regu-
lating mechanisms. The number of events required to cause
cancer is unknown and probably varies by cancer type, but
modeling studies suggest that some cancers (e.g., lung, breast,
colorectal) may require ﬁve or six steps [18].Figure 1. Trends in invasive cancer rates, 1973e2009. APC ¼ average annual percenta
decreasing in incidence were those with a statistically signiﬁcant APC during 1973e2
Results Program, Available at: http://seer.cancer.gov/. Accessed February 23, 2013.Along with a greater understanding of the origin of cancer has
also come a greater awareness of the heterogeneity of cancer.
What was once understood and treated as a single disease is now
thought to comprise distinct types, each of which may have
different etiologies and different options for prevention. Breast
cancer is a good example. Recent work has divided breast cancer
into ﬁve intrinsic subtypes. One of these subtypes (basal-like)
was characterized by up-regulation of certain proliferation genes
and nonexpression of the estrogen receptor (ER), progesterone
receptor (PR), and HER-2 receptor [19,20]. A related clinical
phenotypedthe triple-negative cancer (negative for the ER, PR,
and HER-2 receptors)dhas received much recent attention.
Basal-like or triple negative tumors are typically more aggres-
sive, tend to occur in women younger than 40 years of age, and
have a worse prognosis than tumors expressing these receptor
markers [21,22]. Given their phenotypic differences, researchers
have proposed that basal-like or triple negative tumors may have
a different etiology from other subtypes of breast cancer. For
example, a recent analysis of pooled data found that obesity and
reproductive factors (e.g., nulliparity, increasing age at ﬁrst
childbirth) were associated with increased risks for ERþ/PRþ
breast cancer but not triple-negative cancer [23].The Interaction of Genes and Environment
As the genomic changes that lead to cancer have become
better understood, so too has the importance of the interaction
between genes and the environment in cancer development. For
example, geneeenvironment interactions are thought to explain
why some smokers get lung cancer, butmost do not [24]. Tobacco
smoke contains numerous known carcinogens including poly-
cyclic aromatic hydrocarbons, N-nitrosamines, aromatic amines,
aldehydes, benzene, and butadiene. Polymorphisms in genes
that metabolize tobacco byproducts (e.g., CYP gene superfamily
and glutathione S-transferases) may explain differences in
people’s risk for tobacco-related cancers [25]. Similarly, risk for
alcohol-related cancers may be related to variation in genes that
metabolize alcohol (e.g., ADH1 family, ALDH2, CYP family,
MTHFR) [26,27].ge change, 1973e2009. *Statistical signiﬁcance. Cancers deﬁned as increasing or
009. Data from National Cancer Institute’s Surveillance, Epidemiology, and End
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great potential for understanding cancer etiology. However, good
study design and methodological rigor are of paramount
importance. To assess these associations and interactions
appropriately and accurately, studies must be large, replicable,
and well-powered with appropriate case and control selection
criteria [28].
Applying what we learn about geneeenvironment interac-
tions to preventive interventions highlights an important
distinction between individual and population-based strategies
for prevention. More than 25 years ago, Rose described the
differences between preventing high-risk individuals from
getting cancer and reducing the incidence of cancer in a large
population [29]. The goal of selecting high-risk individuals for
preventive activities shares some features with research in
genomics and its promises of delivering personalized
preventiondthe goal being to identify individuals with predic-
tive genetic markers of susceptibility. A parallel process is the
development of statistical risk prediction modelsdthe most
well-known being the Gail model for predicting risk for devel-
oping breast cancer [30]. However, evenwell-establishedmodels
lack accuracy in predicting future disease in individuals [31,32].
Furthermore, applying a high-risk prevention strategy to the
average-risk population is challenging and costly. It requires that
everyone in a population be screened to determine which indi-
viduals are at high risk. Among other challenges to the individual
strategy, some high-risk individuals may not have access to
health care or bemotivated to seek preventive care and therefore
may not be reached. Another problem with the high-risk indi-
vidual strategy is that it focuses only on susceptible persons and
does not alter the underlying causes of disease for the population
at large [29]. From what we learned through studies of human
genes that predispose people to cancer, a large majority of the
population may be at intermediate risk for the disease [33].
Attributable Risk Estimates
More than three decades ago, two eminent British epidemi-
ologists, Sir Richard Doll and Sir Richard Peto, were commis-
sioned by the Ofﬁce of Technology Assessment, U.S. Congress, to
review the evidence on ways to avoid cancer and to quantify
reductions in death rates that could be achieved by preventive
measures taken during the next one to two decades. Because
cancer incidence data were not available at that time, Doll and
Peto examined variations in cancer deaths among adults aged
35e64 in different geographic areas and some epidemiologic
study results. In their report on the causes of cancer, Doll and
Peto [34] estimated that 25%e40% of cancer-related deaths could
be attributed to tobacco use (best estimate 30%), 10%e70% could
be attributed to poor diet (best estimate 35%), and a much
smaller percentage could be attributed to occupation (4%),
pollution (2%), and other factors or class of factors.
Many leading cancer control investigators characterize the
Doll and Peto report as a landmark article [35e37]. In 1996, the
Harvard Center for Cancer Prevention updated the report [38]
and concurred with the Doll and Peto best estimates for most
risk factors. The most signiﬁcant difference between the 1981
report and the updated version is that the 35% estimate of risk
attributed to poor diet is now attributed to a combination of poor
diet or obesity (30%) and sedentary lifestyle (5%). In the Harvard
update, the estimates were presented as point estimates without
ranges and the sum of all estimates totaled exactly 100%. Manyauthoritative institutions, including the Institute of Medicine [1],
the American Cancer Society [39], and the World Health Orga-
nization [40], cite these estimates or close approximations to
emphasize the importance of tobacco use and poor diet relative
to other risk factors for cancer.
Many epidemiologists, however, criticize the methods of Doll
and Peto and their estimates of attributable proportions [41,42].
The editors of Modern Epidemiology [43] used the Doll and Peto
1981 report to illustrate the inappropriate interpretation of
attributable fractions. Because cancer has multiple causes that
interact with each other at different points in life, the sum of
attributable fractions of causes for cancer is not 100%; instead,
the sum is inﬁnite [43]. This important caveat about attributable
fractions for cancer is often not recognized, and pie charts and
tables showing the causes of cancers commonly add neatly to
100% [37,38,44,45].
The attributable fraction is a tool that epidemiologists can use
to make study results relevant for public health policy or to
garner resources [37,46]. Others argue that when diseases have
multiple causes (e.g., cancer), attributable fractions are mean-
ingless and should not be used to rank individual causes [42,47].
From a cross-discipline perspective, ranking cancer causes in
order of importance can be counterproductive because it fosters
competition between disciplines rather than collaboration. One
might expect that different disciplines would compete to claim
a bigger piece of the pie, when increasingly, the value of working
across disciplines to gain new knowledge and ﬁnd new ways of
solving problems is being recognized [48].
Environmental health scientists criticize the low attribut-
able fractions assigned to environmental and occupational
exposures on many grounds: for example, the fractions are
based on unveriﬁed assumptions and exclude experimental
evidence [41,42]. In addition, Doll’s undisclosed consultancy
work for the chemical industry led some to question whether
he had a conﬂict of interest [49]. After hearing presentations
from many leading experts on environmental cancer risks, the
recent President’s Cancer Panel on reducing environmental
cancer risk concluded that the widely quoted estimates of Doll
and Petowere “woefully out of date” and that the true burden of
environmentally induced cancer had been “grossly under-
estimated” [50].
The simplistic ranking of broad classes of risk factors can no
longer be characterized as consistent with current scientiﬁc
evidence and may actually impede the advancement of scientiﬁc
knowledge across different disciplines. Because most cancers are
multifactorial with multiple etiologic pathways, prevention may
be possible by focusing on several different factors at multiple
periods during the lifespan.
Clinical Dimensions of Cancer Prevention
Since the mid-1970s, some health care professionals include
various aspects of cancer control in the term cancer control
continuum: prevention, detection, diagnosis, treatment, and
survivorship [51,52]. This term is very similar to the term
continuum of cancer care, which describes the delivery of health
care during all phases of illness from diagnosis to death [53].
Including cancer prevention in the cancer control continuum
expands the traditional focus of cancer care beyond diagnosis
and treatment.
Because cancer prevention is linked with other components
of the medical care system through this cancer control
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screening for breast or colon cancer, counseling about tobacco
cessation, vaccination against infectious agents that increase risk
for cancer (e.g., human papillomavirus, hepatitis B), and che-
moprevention (e.g., Tamoxifen, Raloxifene). The health care
system, however, is less likely to inﬂuence cancer incidence than
to inﬂuence morbidity and survival [52]. Many prevention
activities occur outside of the health care system, such as policy
interventions and environmental changes [2]. In addition,
including disease prevention on a continuumwith the diagnosis
and treatment of disease creates a paradox: if successful, cancer
preventionwould halt the subsequent phases and thus invalidate
the term continuum.
Deﬁnition of Modiﬁable Risk Factor
Disease prevention is based on the premise that some risk
factors can be modiﬁed or controlled [54]. Cancer risk factors are
often measured at the individual level, and many individual risk
factors (e.g., sex, age, genetic inheritance, sometimes education
and income) are regarded as ﬁxed, not modiﬁable. Modiﬁable or
avoidable risk factors for cancer are typically dichotomized as
either lifestyle or environmental. Lifestyle is often used as an
adjective to characterize individual behaviors, such as tobacco
smoking, poor diet, and physical inactivity [55]. The term lifestyle
implies individual volition. Environment can havemanymeanings
[56], but environmental risk factor usually refers to exposure to
carcinogenic substances and is generally understood as something
over which the individual has little control. During the past 40
years, this dichotomy between lifestyle and environment created
distinct areas of research and practice for cancer prevention.
In recent years, transdisciplinary approaches to disease control
attempt to integrate bodies of knowledge and practice from
avarietyofdisciplines to solveproblems[48]. Rosenﬁelddescribed
this approach as transcending the limits of individual disciplines
and providing “a systematic, comprehensive, theoretical frame-
work for the deﬁnition and analysis of the social, economic,
political, environmental, and institutional factors inﬂuencing
human health and well-being” [57]. For example, Hiatt and Breen
described a transdisciplinary science approach to social determi-
nants that operate at the societal level, the health care system
level, the individual-behavior or psychological level, and the bio-
logical level [52]. The societal level includes factors such as envi-
ronmental contamination, conditions that are unsafe for physical
activity, and food deserts where people have little access to fruits
and vegetables (a factor that disproportionately affects low
socioeconomic [SES] populations). Tobacco use is a good example
of a risk factor that is both behavioral and social, each requiring
different control programs. Among adolescents, community-
based interventions (e.g., increasing the price of tobacco, mass
media campaigns to counter tobacco industry advertising in
combination with other interventions, restricting minors’ access
to tobacco products) are effective strategies for reducing the
proportion of adolescentswhobeginusing tobacco [58]. To reduce
tobacco use among older people, tobacco control switches from
preventing tobacco use to helping tobacco users to quit, because
most new smokers are younger than 18 years old [59].
Social Determinants of Cancer
The distinction between lifestyle and environmental factors is
becoming increasingly blurred as researchers turn their attentionto the social and environmental determinants of health-related
behaviors [60,61]. Several inﬂuential groups call for empha-
sizing social determinants of health, because health is strongly
correlated with educational level and SES [62e64]. Freudenberg
[65] proposes that corporate practices have a dominant inﬂuence
on health-related behaviors by inﬂuencing the social, physical,
and policy factors that shape individual decisions. As with other
health outcomes, many cancers disproportionately affect people
of color and people of low SES [64]. Breast and skin cancer are
notable exceptions, but when those cancer types are diagnosed
in low-SES patients, they generally have poor survival rates [39].
Income inequality is strongly correlated with excess preventable
mortality [66]. The “upstream” social determinants of disease
and health are the neighborhood conditions, environmental
exposures, social and occupational opportunities, and personal
resources that create the context within which health decisions
are made and health behaviors are carried out. The “down-
stream” consequences of such social determinants are damages
to organ systems or genes [52].
One approach that attempts to reconcile individual and
population level characteristics is multilevel analysis [67,68].
This modeling technique allows researchers to identify charac-
teristics of the social structure and ecology of neighborhoods,
which may lead to better designed community interventions
[69]. However, using regression models to investigate complex
chains of relationships between social level and individual
characteristics is methodologically challenging. Ecological and
individual level characteristics rarely exist apart from each other
[70]. Usually, the way in which a social group is organized has
multiple inﬂuences on individual health. The converse is also
true: individuals can affect how their society is organized in
multiple ways. Another challenge is that the relationship
between any one characteristic (e.g., gender, race) and disease
can be more or less important depending on the history of the
community [71]. That is, each social group is unique with respect
to its experiences over time, and these group experiences
become part of all group members’ experience whether or not
they actually lived those experiences [72]. The recognition that
society-, individual-, and gene-level characteristics operate
together, and possibly synergistically, to inﬂuence illness and
health is an important shift from the traditional, individual-
based or strictly environmental models of risk factors and
disease.
Despite the recognized importance of this shift, however, the
model of multiple levels of inﬂuence on health outcomes comes
under some criticism. Krieger criticized the language of “levels”
and the distinction between “proximal” and “distal” causes and
between “upstream” and “downstream” factors as conﬂating
levels with causal strength. Changes in “distal” or “upstream”
factors do not have towork through all intervening levels and are
not limited to a distant, weak effect but can directly and strongly
affect cancer risk for individuals [73]. For example, interventions
at the social and policy level can directly affect the health of
individuals, as in the case of environmental regulations that
reduce individuals’ exposure to toxic contamination.
When to Take Action
Approaches to cancer prevention have included harm
reduction (reducing exposure to known causes of cancer), clin-
ical interventions (vaccines, chemoprevention), and health
promotion (promoting behaviors that are associated with
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take action may vary depending on the type of preventive
approach. The U.S. Preventive Services Task Force requires the
strongest levels of evidence before making recommendations on
clinical preventive services for the general population [74]. Also,
the Guide to Community Preventive Services looks for method-
ologically strong studies when conducting reviews of effective
interventions in communities [75].
When the focus is on reducing harm from a particular expo-
sure, the available scientiﬁc evidence rarely includes controlled
clinical trials or controlled interventions in community settings.
The President’s Cancer Panel Report highlighted the vast number
of chemicals that the public is routinely exposed to that may be
carcinogenic, but are yet to be adequately researched [50].
Although much more research needs to be conducted on
chemical exposures as well as in other realms of cancer
prevention in order to have actionable evidence, scientists, policy
makers and public health organizations must consider the
thresholds of evidence that they deem necessary to warrant
intervening on potentially harmful or protective factors. Issues
surrounding the level of evidence necessary for action have been
encountered in many realms of prevention science [76e83].
When the goal is to determine if sufﬁcient evidence exists to
justify taking precautionary action, the results of observational
and epidemiologic studies and animal models should be taken
into consideration and a different threshold of evidence may be
appropriate. By better deﬁning the levels of evidence necessary
to implement different types of interventions to prevent cancer,
this research may be able to become more targeted, generate
more actionable results, and shorten the 17-year lag from
research to practice [84].
During the past 40 years, our approaches to cancer prevention
had limited success, whereas scientiﬁc understanding of the
complex process of cancer development has advanced to provide
new insights into causation and prevention. New approaches to
cancer prevention must use this expanded scientiﬁc knowledge
and our understanding of the interplay between various cancer
risk factors at multiple levels within a particular social and
historical setting. The labeling of exposures or risk factors as
either lifestyle or environmental and rank ordering of risk factors
shapes our approach to prevention, may limit opportunities for
change, and is not consistent with current scientiﬁc knowledge.
Prevention practices might beneﬁt from an examination of
exposures usually termed environmental to see how behaviors
and actions by individuals inﬂuence personal exposures, envi-
ronmental degradation, and societal changes. Likewise, a better
understanding is needed on how social, economic, and envi-
ronmental circumstances can inﬂuence, support or limit “life-
style” and other behaviors at different stages of life. The recently
released National Prevention Strategy aims to increase the
number of Americans who are healthy at every stage of life by
integrating actions across multiple settings and presents an
approach that is highly relevant for cancer prevention [85].
We believe that it is possible for today’s youth, as they grow
older, to experience lower cancer incidence rates than previous
generations.We need to adopt amore transdisciplinary approach
to prevention [48], adapted as appropriate for different stages of
life. In the future, the greatest improvements in cancer preven-
tion might occur as a result of innovative, multilevel interven-
tions that build on the expanding base of scientiﬁc evidence. The
articles in this special issue of the Journal of Adolescent Health
elaborate further on preadolescence and adolescence as a specialperiod of vulnerability [86e93]. Several articles describe inno-
vative approaches and practical challenges to cancer prevention
at this stage of life [94e99]. Collectively, these articles suggest
several promising opportunities and directions for cancer
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